Clinical trial

Extended Duration Artemether-lumefantrine Treatment for Malaria in Children

NCT03453840

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-02-21

PhasePHASE4

Study timeline

Study start (actual)2018-02-21Date precision: day

Registry last updated2025-04-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Uncomplicated Plasmodium Falciparum Malariaunresolved

Interventions

Artemether-lumefantrineDRUG

Sponsors & collaborators

University of California, San Franciscolead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Yale Universitycollaborator

Infectious Diseases Research Collaboration, Ugandacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03453840 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.